Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2
about
The analgesic efficacy of fentanyl: relationship to tolerance and mu-opioid receptor regulationChronic opioid therapy and opioid tolerance: a new hypothesisIdentification of the First Marine-Derived Opioid Receptor "Balanced" Agonist with a Signaling Profile That Resembles the EndorphinsBiomarkers of morphine tolerance and dependence are prevented by morphine-induced endocytosis of a mutant mu-opioid receptor.The interpersonal dimension of borderline personality disorder: toward a neuropeptide model.Abnormal nociception and opiate sensitivity of STOP null mice exhibiting elevated levels of the endogenous alkaloid morphineChange in functional selectivity of morphine with the development of antinociceptive tolerance.Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance.Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to humanFentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice.Effects of repeated oxycodone administration on its analgesic and subjective effects in normal, healthy volunteers.Differences in the characteristics of tolerance to μ-opioid receptor agonists in the colon from wild type and β-arrestin2 knockout miceRegulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.Quantitative encoding of the effect of a partial agonist on individual opioid receptors by multisite phosphorylation and threshold detection.Agonist-specific regulation of mu-opioid receptor desensitization and recovery from desensitizationHydromorphone efficacy and treatment protocol impact on tolerance and mu-opioid receptor regulation.Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat.Regulation of opioid receptor signalling: implications for the development of analgesic tolerance.Stereochemical basis for a unified structure activity theory of aromatic and heterocyclic rings in selected opioids and opioid peptidesOpioid modulation of resting-state anterior cingulate cortex functional connectivity.Deciphering µ-opioid receptor phosphorylation and dephosphorylation in HEK293 cells.The role of amygdalar mu-opioid receptors in anxiety-related responses in two rat models.Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro AssaysLigand-specific regulation of the endogenous mu-opioid receptor by chronic treatment with mu-opioid peptide agonistsSystemic daily morphine enhances the analgesic effect of intrathecal dexmedetomidine via up-regulation of alpha 2 adrenergic receptor subtypes A, B and C in dorsal root ganglion and dorsal horn.Low Molecular Weight Opioid Peptide Esters Could be Developed as a New Class of AnalgesicsLong-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal.In vitro and in vivo characterisation of the bifunctional MOP/DOP ligand UFP-505.
P2860
Q24648701-6D798538-4179-49C0-8A41-6D14D8EB823BQ28709400-3E63C7F4-449D-4D26-B415-E73A85788BFCQ30841944-75C3B0AA-419C-4D4F-A59A-15DE25F8ECF8Q33613252-35358141-0C7A-42AC-8B36-213EC741004FQ34252326-EE974B25-FE72-44E1-AE1D-11A508241154Q34471271-6B1F08F0-C220-4C88-8F21-ECE91FDC3314Q34939824-D004A7B7-9E02-45A1-A96B-F9087687133EQ35264421-AC508EE1-2E4B-4E81-B8DC-4138875318CDQ35589969-64ADD362-5789-4087-B905-C95CAA36A211Q35860275-42179ACE-7A7F-47FE-939A-AA49C1578CC8Q35927404-09DCD3BF-31C2-4D1C-8DB8-54688471CE9EQ35980825-D00619B8-AB2B-4366-8661-3B8EF252C93BQ36591603-16125831-2CAE-49E1-898A-0845F4F2F32FQ36763815-2A16AE2F-2A8B-42F0-8211-8B7218EA4393Q36807249-F494944A-EDF7-4B48-8860-F9EF0972A8D7Q36982400-25DF8DC6-8669-4E3B-A336-2430659EFD7AQ37645588-75141E6E-593F-4B38-AEBD-1A54487C3B28Q37887853-AAA8154C-3163-4A53-BE54-EB593DE4898FQ39407401-29E9CEA7-F32C-4501-B5B5-73CA96D2265FQ41689363-87AE37E8-93C2-4446-A230-1E7D7CC0AED6Q42000724-95EE353E-1330-4CBB-B26F-403CA018BA6FQ42022457-57455B69-6B02-43D5-BBAC-4C7BF7F01B5BQ42713279-10C9B6E6-2396-4062-8229-A27C7B3EA6B0Q42825684-BC22A7F7-09C3-42FF-96BD-20A6E01EDC18Q42835433-7DF93BE5-706F-46BB-ACAC-70C07F6FBC6FQ42860558-E8897670-273F-4CC3-8029-4943653069BFQ45063674-8E70EBB3-9B42-4B61-A7DD-2020ED5D14B0Q51741932-4B348CE3-7598-4003-B414-576A509EA89C
P2860
Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Opioid agonist efficacy predic ...... opioid receptors and dynamin-2
@ast
Opioid agonist efficacy predic ...... opioid receptors and dynamin-2
@en
type
label
Opioid agonist efficacy predic ...... opioid receptors and dynamin-2
@ast
Opioid agonist efficacy predic ...... opioid receptors and dynamin-2
@en
prefLabel
Opioid agonist efficacy predic ...... opioid receptors and dynamin-2
@ast
Opioid agonist efficacy predic ...... opioid receptors and dynamin-2
@en
P2093
P2860
P1476
Opioid agonist efficacy predic ...... opioid receptors and dynamin-2
@en
P2093
Byron C Yoburn
Ellen A Walker
Mohit Pawar
Soujanya Sunkaraneni
P2860
P304
P356
10.1016/J.EJPHAR.2007.01.059
P407
P577
2007-02-08T00:00:00Z